PL1931704T3 - Wytwarzanie i oczyszczanie IL-29 - Google Patents

Wytwarzanie i oczyszczanie IL-29

Info

Publication number
PL1931704T3
PL1931704T3 PL06816409T PL06816409T PL1931704T3 PL 1931704 T3 PL1931704 T3 PL 1931704T3 PL 06816409 T PL06816409 T PL 06816409T PL 06816409 T PL06816409 T PL 06816409T PL 1931704 T3 PL1931704 T3 PL 1931704T3
Authority
PL
Poland
Prior art keywords
methods
production
purification
coli
vectors
Prior art date
Application number
PL06816409T
Other languages
English (en)
Inventor
Bruce L Zamost
Geoffrey F Lee
Robert M Dedinsky
Original Assignee
Zymogenetics L L C
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics L L C, Bristol Myers Squibb Co filed Critical Zymogenetics L L C
Publication of PL1931704T3 publication Critical patent/PL1931704T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
PL06816409T 2005-10-04 2006-10-04 Wytwarzanie i oczyszczanie IL-29 PL1931704T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72354405P 2005-10-04 2005-10-04
EP06816409A EP1931704B1 (en) 2005-10-04 2006-10-04 Production and purification of il-29
PCT/US2006/039139 WO2007041713A1 (en) 2005-10-04 2006-10-04 Production and purification of il-29

Publications (1)

Publication Number Publication Date
PL1931704T3 true PL1931704T3 (pl) 2011-06-30

Family

ID=37603659

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06816409T PL1931704T3 (pl) 2005-10-04 2006-10-04 Wytwarzanie i oczyszczanie IL-29

Country Status (15)

Country Link
US (6) US20080096252A1 (pl)
EP (1) EP1931704B1 (pl)
JP (3) JP5364375B2 (pl)
AT (1) ATE491722T1 (pl)
AU (1) AU2006299339B2 (pl)
CA (1) CA2625208A1 (pl)
CY (1) CY1112323T1 (pl)
DE (1) DE602006018969D1 (pl)
DK (1) DK1931704T3 (pl)
ES (1) ES2357152T3 (pl)
IL (2) IL189994A (pl)
PL (1) PL1931704T3 (pl)
PT (1) PT1931704E (pl)
SI (1) SI1931704T1 (pl)
WO (1) WO2007041713A1 (pl)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2367891T3 (es) 2000-09-29 2011-11-10 Schering Corporation Interleucina-10 pegilada.
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
ATE388963T1 (de) * 2003-08-07 2008-03-15 Zymogenetics Inc Homogene herstellungen von il-29
CA2616122A1 (en) * 2005-07-20 2007-01-25 Zymogenetics, Inc. Il28 and il29 truncated cysteine mutants and antiviral methods of using same
JP4987001B2 (ja) * 2005-07-20 2012-07-25 ザイモジェネティクス リミテッド ライアビリティ カンパニー 癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
CA2625208A1 (en) 2005-10-04 2007-04-12 Zymogenetics, Inc. Production and purification of il-29
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
CL2008002053A1 (es) 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
BRPI0817026A2 (pt) 2007-09-20 2017-05-16 Australian Poultry Crc Pty Ltd molécula de ácido nucleico, polipeptídeo isolado, polipeptídeo de fusão, construção genética, métodos para produzir uma molécula de interferon-lambda recombinante aviário em uma célula, para identificar uma sequência genética de interferon-lambda aviário, para induzir ou regular de modo positivo uma resposta imune em aves e para o tratamento ou profilaxia de aves, molécula de interferon-lambda recombinante aviário, célula isolada, molécula de anticorpo, meio legível por computador, ensaio para mdir o nível de um polipeptídeo de interferon-lambda aviário em aves, uso do polipeptídeo de interferon-lambda aviário ou de uma molécula de ácido nucleico, gênero alimentício medicinal ou terapêutico, adjuvante, e, composição farmacêutica veterinária.
CA2711375C (en) 2008-01-18 2019-04-16 F. Hoffmann-La Roche Ag Purification of not-glycosylated polypeptides
CA2727026A1 (en) * 2008-06-05 2009-12-10 Zymogenetics, Llc Use of pegylated type iii interferons for the treatment of hepatitis c
EP2350271B1 (en) 2008-11-20 2016-01-27 Biogen MA Inc. Arginine inactivation of enveloped viruses
CA2745443C (en) * 2008-12-17 2017-02-21 Schering Corporation Mono- and di-peg il-10 production; and uses
WO2010118409A1 (en) * 2009-04-10 2010-10-14 Ls9, Inc. Production of commercial biodiesel from genetically modified microorganisms
WO2011098644A2 (es) 2010-02-09 2011-08-18 Proyecto De Biomedicina Cima, S.L. Composiciones para el tratamiento de enfermedades infecciosas y tumorales
JP5768341B2 (ja) * 2010-08-04 2015-08-26 東ソー株式会社 Ｆｃ結合性タンパク質の製造方法
CN102584979B (zh) * 2011-01-18 2015-10-14 北京凯因科技股份有限公司 PEG化干扰素λ
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
CA2846092A1 (en) * 2011-08-25 2013-02-28 Nanogen Pharmaceutical Biotechnology Peg-interferon lambda 1 conjugates
US8454947B1 (en) 2012-03-01 2013-06-04 Nanogen Pharmaceutical Biotechnology PEG-interferon lambda 1 conjugates
RU2549710C2 (ru) * 2012-06-29 2015-04-27 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Способ очистки рекомбинантного белка интерфероноподобного фактора iii типа
JP6086378B2 (ja) * 2012-11-30 2017-03-01 国立大学法人お茶の水女子大学 組み換えヒト膵臓リパーゼの調製方法
CN104045704B (zh) * 2013-03-11 2016-08-10 中国医学科学院基础医学研究所 PEG化重组人IFN-λ1、其制备方法和用途
RU2679889C2 (ru) 2013-04-18 2019-02-14 Армо Байосайенсиз, Инк. Способы применения интерлейкина-10 для лечения заболеваний и расстройств
CA2914837A1 (en) 2013-06-17 2014-12-24 Armo Biosciences, Inc. Method for assessing protein identity and stability
WO2015008302A1 (en) * 2013-07-19 2015-01-22 Biogenomics Limited Apparatus for refolding of recombinant proteins
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
WO2015070060A1 (en) 2013-11-11 2015-05-14 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
EP3954714A1 (en) * 2014-01-08 2022-02-16 Prosit Sole Biotechnology (Beijing) Co. Ltd Fusion polypeptides and methods of use
US10076512B2 (en) 2014-05-01 2018-09-18 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
US11311519B2 (en) 2014-05-01 2022-04-26 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
CN106573072A (zh) 2014-06-02 2017-04-19 阿尔莫生物科技股份有限公司 降低血清胆固醇的方法
EP3206713A4 (en) 2014-10-14 2018-06-27 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
CN107106655A (zh) 2014-10-22 2017-08-29 阿尔莫生物科技股份有限公司 使用白细胞介素‑10治疗疾病和病症的方法
CA2969574A1 (en) * 2014-12-23 2016-06-30 Armo Biosciences, Inc. Methods of improving yield in recombinant protein production
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
KR102514971B1 (ko) 2015-04-21 2023-03-27 아이거 바이오파마슈티컬스 인코포레이티드 로나파르닙 및 리토나버를 포함하는 약제 조성물
EP3302547A1 (en) 2015-05-28 2018-04-11 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
AU2016312510A1 (en) 2015-08-25 2018-03-08 Armo Biosciences, Inc. Methods of using Interleukin-10 for treating diseases and disorders
PL3416675T3 (pl) 2016-02-19 2021-10-11 Eiger Biopharmaceuticals, Inc. Leczenie zakażenia wirusem zapalenia wątroby typu delta za pomocą interferonu lambda
WO2018085769A1 (en) * 2016-11-07 2018-05-11 Seattle Genetics, Inc. Distribution of engineered-cysteine caps

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795077A (en) * 1988-05-23 1989-01-03 Motorola Inc. Bonding method and apparatus
EP0626448A3 (de) 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
WO2000032772A2 (en) * 1998-11-30 2000-06-08 Eli Lilly And Company Erythropoietic compounds
CZ299516B6 (cs) * 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
EP1294888B1 (en) * 2000-06-30 2007-04-25 ZymoGenetics, Inc. Interferon-like protein zcyto21
US7038032B2 (en) * 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
WO2004037995A2 (en) * 2002-10-23 2004-05-06 Zymogenetics, Inc. Methods for treating viral infection using il-28 and il-29
EP1573006B1 (en) * 2002-12-13 2009-11-11 ZymoGenetics, Inc. Il-21 production in prokaryotic hosts
ATE388963T1 (de) * 2003-08-07 2008-03-15 Zymogenetics Inc Homogene herstellungen von il-29
WO2005097165A2 (en) 2004-04-02 2005-10-20 Zymogenetics, Inc. Il-28 and il-29 cysteine mutants for treating viral infection
WO2006012644A2 (en) * 2004-07-29 2006-02-02 Zymogenetics, Inc. Use of il-28 and il-29 to treat cancer
CN1305902C (zh) * 2004-11-25 2007-03-21 汕头大学医学院 一种人白细胞介素29的生产方法及重组il－29工程菌
PT1828239E (pt) * 2004-12-10 2011-10-27 Zymogenetics Inc Produção de fgf18 em hospedeiros procarióticos
JP4987001B2 (ja) * 2005-07-20 2012-07-25 ザイモジェネティクス リミテッド ライアビリティ カンパニー 癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
CA2625208A1 (en) * 2005-10-04 2007-04-12 Zymogenetics, Inc. Production and purification of il-29

Also Published As

Publication number Publication date
IL227691A0 (en) 2013-09-30
US20120271037A1 (en) 2012-10-25
CA2625208A1 (en) 2007-04-12
US20080096252A1 (en) 2008-04-24
PT1931704E (pt) 2011-03-28
ATE491722T1 (de) 2011-01-15
US20130143270A1 (en) 2013-06-06
IL189994A (en) 2013-08-29
US8211670B2 (en) 2012-07-03
JP2013099337A (ja) 2013-05-23
US7968315B2 (en) 2011-06-28
CY1112323T1 (el) 2015-12-09
US20120015403A1 (en) 2012-01-19
AU2006299339B2 (en) 2012-03-15
ES2357152T3 (es) 2011-04-19
JP5364375B2 (ja) 2013-12-11
DE602006018969D1 (de) 2011-01-27
AU2006299339A1 (en) 2007-04-12
SI1931704T1 (sl) 2011-04-29
EP1931704A1 (en) 2008-06-18
DK1931704T3 (da) 2011-03-14
WO2007041713A1 (en) 2007-04-12
US20100003722A1 (en) 2010-01-07
IL189994A0 (en) 2008-08-07
US8759027B2 (en) 2014-06-24
JP2012235789A (ja) 2012-12-06
JP2009510173A (ja) 2009-03-12
US20100222552A1 (en) 2010-09-02
US7759092B2 (en) 2010-07-20
EP1931704B1 (en) 2010-12-15

Similar Documents

Publication Publication Date Title
IL227691A0 (en) Creation and purification of 29 – il
ATE492633T1 (de) Polypeptide mit cellobiohydrolaseaktivität und dafür kodierende polynukleotide
PL1948789T3 (pl) Sposób wytwarzania ciągłych ludzkich linii komórkowych
MY172991A (en) Interleukin-2 muteins for the expansion of t-regulatory cells
SG10201407329RA (en) Modified vasoactive intestinal peptides
MX2009012846A (es) Polipeptidos que tienen actividad celulosica mejorada y polinucleotidos que los codifican.
ATE515568T1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
TW200740841A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same
MX2012015142A (es) Polipeptidos que tiene actividad beta-glucosidasa y usos del mismo.
EP3805348A3 (en) Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
AU2010325787A8 (en) Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof
UA95083C2 (ru) Азеотропная или близкая к азеотропной композиции, которые содержат 1,1,1,2,3-пентафторопропен и фтороводород, способы отделения и получения 1,1,1,2,3-пентафторопропена
MX2012003473A (es) Polipeptidos que tienen actividad celulitica mejorada y polinucleotidos que codifican para los mismos.
SI1941027T1 (sl) Postopki in sredstva za proliferacijo zarodnih celic in kasnejšo generacijo in ekspanzijo progenitorskih celic, kot tudi izdelava efektor celic kot kliničnih zdravil
ATE521633T1 (de) Fgf18 produktion in prokaryotischen zellen
MX2011010494A (es) Polipeptidos que tienen actividad de celulasa.
ATE447013T1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
TW200621284A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same
MX2013002554A (es) Metodo para purificar eritropoyetina conjugada con polietilenglicol (peg).
MX2008002485A (es) Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que los codifican.
AU2003223124A1 (en) Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same
BR112012017243A2 (pt) constructos terapêuticos de apirase, agentes de apirase, e métodos de produção
MX2012006095A (es) Polipeptidos que tienen actividad glucoamilasa y polinucleotidos que codifican para los mismos.
TW200621285A (en) Polypeptides having antimicrobial activity and polyncleotides encoding same
TW200617021A (en) Isolated photoprotein aequorin y89f, and its use